ERBB2 and breast cancer: BC can be categorised based on immunohistochemical profiles and hormone receptor expression as oestrogen receptor-positive (ER+), progesterone receptor-positive (PR+), triple negative (TN−), and human epidermal growth factor receptor-positive (HER2+).